Sir Brian Barratt-Boyes KBE |
|
---|---|
![]() |
|
Born |
Brian Gerald Boyes 13 January 1924 Wellington, New Zealand |
Died | 8 March 2006 Cleveland, Ohio, USA |
(aged 82)
Alma mater | University of Otago |
Spouse(s) |
Norma Margaret Thomson (m. 1949; div. 1986) Sara Rose Monester (m. 1986) |
Sir Brian Gerald Barratt-Boyes KBE (born Brian Gerald Boyes, 13 January 1924 – 8 March 2006) was a pioneering heart surgeon from New Zealand.
Born in Wellington on 13 January 1924, Barratt-Boyes was educated at Wellington College. After a year at Victoria University College, he studied medicine at Otago's Medical School, graduating in 1946. He continued his training as a surgeon, initially in New Zealand, and later at the Mayo Clinic (1953-55) and as a Nuffield Fellow in Bristol (1955-56). At Mayo he worked under John W. Kirklin, the two developing a high mutual regard that endured and grew over the years.
Barratt-Boyes married physiotherapist Norma Margaret Thomson in Dunedin on 9 November 1949. The couple went on to have five sons.
In 1956 he was recruited back to Auckland, New Zealand by Sir Douglas Robb, and pioneered the development of cardiopulmonary bypass in that country, the first patient being operated on in 1958. While this task must have been made more difficult by New Zealand's relative remoteness and small population, the Greenlane Hospital surgical team quickly achieved an international reputation for innovative excellence. Indeed, he suggested that Auckland's isolation conferred an advantage comparable to that enjoyed by the Mayo Clinic in small-town Rochester, Minnesota, making it less likely that day-to-day interruptions would interfere with the real purpose of their work. Much of the original equipment had to be fashioned or modified locally. Sid Yarrow, an engineer on the team, built an early external pacemaker for intra-operative use. The first permanent unit, from Medtronic, was implanted in 1961.
In 1962 he introduced, independently but simultaneously with Donald Ross in London, the human cadaveric aortic homograft for aortic valve replacement and for many years he worked to perfect valve preparation, emphasizing its inherent physiologic advantages and simplifying its surgical implant technique. He and his team's results became the standard for others to match.